Overview

Myopathy is a general term for diseases in which the primary problem lies within skeletal muscle fibers, producing weakness and impaired contraction. The word derives from Greek roots for muscle and suffering; it denotes pathology of the muscle rather than of the nerves, joints, or central nervous system. Affected people commonly experience reduced strength, exercise intolerance, cramps, stiffness, or muscle pain.

Causes and classification

Myopathies are heterogeneous. They can be inherited (genetic) or acquired. Major categories include:

  • Inherited structural disorders such as the various muscular dystrophies.
  • Inflammatory myopathies (immune-mediated conditions) including polymyositis and dermatomyositis.
  • Metabolic and mitochondrial myopathies related to energy production defects.
  • Endocrine and systemic disease–related myopathies (for example, thyroid or adrenal disorders).
  • Drug- or toxin-induced myopathies (statins, alcohol, certain medications).

These groups overlap in presentation, and some conditions are classified at the intersection of neuromuscular and musculoskeletal medicine.

Symptoms, signs, and typical patterns

Weakness is the hallmark. Myopathies often produce proximal weakness (shoulders, hips) but some genetic or metabolic forms affect distal muscles. Other features can include muscle wasting, cramps, spasms, myalgias, and fatigue. Severe cases may compromise breathing or heart function when respiratory or cardiac muscles are involved.

Evaluation and diagnosis

Diagnosing myopathy typically combines clinical assessment with laboratory and specialized tests. Common tools are:

  • Blood tests: muscle enzymes such as creatine kinase (CK).
  • Electromyography (EMG) to distinguish myopathic from neurogenic patterns.
  • Neuroimaging or muscle MRI to localize involved muscles.
  • Muscle biopsy to examine fiber changes, inflammation, or mitochondrial abnormalities.
  • Genetic testing and autoantibody panels for inherited or immune-mediated causes.

These investigations help determine prognosis and guide therapy.

Treatment, management, and prognosis

Treatment depends on the cause. Immune-mediated myopathies may respond to immunosuppressive medications and corticosteroids. Supportive care—physical therapy, occupational therapy, assistive devices, and management of respiratory or cardiac complications—is central for many forms. For some inherited disorders, specific interventions (including emerging gene-based therapies) or symptomatic treatments can improve function and quality of life. Prognosis varies widely: some myopathies are slowly progressive and manageable, while others may cause significant disability.

Terminology and distinctions

By definition a myopathy denotes muscle-originating disease, distinguishing it from neuropathies or central nervous system conditions that secondarily affect movement. For a concise etymological note, see the Greek components myo- and -pathy. For general patient information and clinical overviews consult resources titled muscle disease and anatomical references for muscle.

Notable facts: some myopathies present in childhood while others appear in adulthood; management often requires a multidisciplinary team including neurologists, cardiologists, pulmonologists, rehabilitation specialists, and genetic counselors.